MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. achieved a net profit attributable to the parent company of 4.98 billion yuan in 2024, an increase of 1.1% year-on-year.

date
21:44 27/02/2025
avatar
GMT Eight
MicroPort Medical (00853) releases the performance of HeartRhythm Medical Technology for the 12 months ending December 31, 2024, with revenues...
MICROPORT(00853) announced the performance of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. for the 12 months ending on December 31, 2024. The revenue was 1.206 billion yuan, an increase of 1.6% compared to the previous year. The net profit attributable to the equity holders of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. was 498 million yuan, an increase of 1.1% compared to the previous year.